Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Kodiak Sciences ( (KOD) ).
On December 16, 2025, Kodiak Sciences Inc. entered into an underwriting agreement with a syndicate of major investment banks for a public offering of its common stock, initially covering 6,956,522 shares at a price to the public of $23.00 per share, with the underwriters purchasing at $21.62 per share and holding a 30-day option for up to an additional 1,043,478 shares. The underwriters exercised this option in full on December 17, 2025, and Kodiak completed the issuance and sale of a total of 8,000,000 shares on December 18, 2025, generating approximately $184 million in gross proceeds before fees and expenses under customary underwriting terms, bolstering the company’s capital position and financial flexibility for its ongoing business and development activities.
The most recent analyst rating on (KOD) stock is a Hold with a $14.00 price target. To see the full list of analyst forecasts on Kodiak Sciences stock, see the KOD Stock Forecast page.
Spark’s Take on KOD Stock
According to Spark, TipRanks’ AI Analyst, KOD is a Underperform.
Kodiak Sciences faces significant financial challenges with no revenue and substantial losses, placing it at the lower end of the scoring range. Its technical indicators show short-term positive momentum, but with caution due to overbought signals and broader downtrend pressures. The valuation reflects the typical high-risk, high-reward scenario of early-stage biotech firms.
To see Spark’s full report on KOD stock, click here.
More about Kodiak Sciences
Kodiak Sciences Inc. is a biopharmaceutical company focused on developing therapies, particularly in ophthalmology, and it accesses capital markets through public offerings of its common stock to fund its operations and pipeline development.
Average Trading Volume: 982,776
Technical Sentiment Signal: Buy
Current Market Cap: $1.28B
Find detailed analytics on KOD stock on TipRanks’ Stock Analysis page.